Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Is it possible in fiscal term 2006 for Sankyo and Daiichi Pharmaceutical to each compensate for the portion of revised drug prices?

April 26, 2017compensate daiichi fiscal pharmaceutical portion possible revised sankyo term

0

Posted

Is it possible in fiscal term 2006 for Sankyo and Daiichi Pharmaceutical to each compensate for the portion of revised drug prices?

1 Answer

0

Posted

A22.There is an impact of approximately 18.0 billion yen to Sankyo for the drug prices revision, and approximately 16.0 billion yen to Daiichi Pharmaceutical. However, we believe that we can secure a revenue at the level of fiscal 2005, with contributions from new products and growth in existing products in Japan at both companies.